Skip to main content
CivicGate

HRES 1195
Introduced Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.

Supporting the designation of May as "National Myositis Awareness Month".

Supporting the designation of May as ``National Myositis Awareness Month''.

Introduced Apr 20, 2026

Latest action (Apr 20, 2026) Referred to the House Committee on Energy and Commerce.

Policy area
Issues
Healthcare

Summary

  • Expresses House support for designating May as "National Myositis Awareness Month."
  • Recognizes the importance of raising awareness of myositis and its impact on U.S. veterans and citizens.
  • Encourages people in the United States to learn more about myositis and to support individuals and families affected by these conditions.
  • Is a nonbinding resolution that does not itself create a designation, appropriate funds, or impose any requirement.
  • Was referred to the House Committee on Energy and Commerce.

AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.

Sponsor (1)

2 cosponsors

Actions (2)

  1. Apr 20, 2026 Referred to the House Committee on Energy and Commerce. · house
  2. Apr 20, 2026 Submitted in House

Full text

IN THE HOUSE OF REPRESENTATIVES

April 20, 2026

Mr. McCormick submitted the following resolution; which was referred to the Committee on Energy and Commerce

RESOLUTION

Supporting the designation of May as “National Myositis Awareness Month”.

Whereas residents of the United States of America are among those affected by myositis and other rare diseases, with nearly 1 in 10 Americans having rare diseases; Whereas idiopathic inflammatory myopathies (collectively referred to as myositis) are rare, chronic, autoimmune muscle-wasting diseases that often feature debilitating muscle inflammation and other symptoms, such as pain, fatigue, and trouble swallowing, and can result in myositis- associated interstitial lung disease; Whereas more research is needed to identify the causes of and modes of treatments for the myositis group of diseases, which includes anti-MDA5 autoantibody-positive myositis, antisynthetase syndrome, dermatomyositis, juvenile dermatomyositis, immune-mediated necrotizing myopathy, inclusion body myositis, and polymyositis; Whereas myositis is difficult to diagnose which leads myositis patients to frequently experience delayed treatment and difficulty finding a health care provider with expertise in their condition; Whereas all who suffer with myositis experience reduced quality of life, particularly since no cure has been found and life expectancy is shortened, especially for those with inclusion body myositis; and Whereas public awareness and education campaigns on myositis detection and treatment are held during the month of May: Now, therefore, be it Resolved, That the House of Representatives—

(1) supports the designation of “National Myositis Awareness Month”;

(2) recognizes the importance of raising awareness about myositis and its impact on United States veterans and citizens; and

(3) encourages all people in the United States to become more informed about myositis and to support the individuals and families who are affected by these conditions. <all>

Text versions (1)

  • Introduced in House · Apr 20, 2026

Only one text version is on file, so there’s no earlier version to compare against yet.

Similar bills (6)

Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.

Comments

Comments

Loading comments…